Parabilis Medicines aims to raise $633 million in upsized US IPO
Biopharmaceutical company Parabilis Medicines said on Tuesday it was aiming to raise as much as $633.3 million in its upsized initial public offering in the U.S.
(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Sahal Muhammed)
Copyright Reuters or USA Today Network via Reuters Connect
This story was originally published June 9, 2026 at 3:16 AM.